Great Diamond Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.5M Sell
3,752
-16
-0.4% -$16.3K 0.77% 34
2026
Q1
$3.47M Sell
3,768
-303
-7% -$307K 0.67% 39
2025
Q4
$4.38M Sell
4,071
-107
-3% -$102K 0.84% 27
2025
Q3
$3.19M Sell
4,178
-79
-2% -$58.8K 0.62% 36
2025
Q2
$3.32M Sell
4,257
-2,353
-36% -$1.83M 0.7% 35
2025
Q1
$5.46M Sell
6,610
-675
-9% -$562K 1.49% 13
2024
Q4
$5.62M Sell
7,285
-109
-1% -$90.3K 1.45% 14
2024
Q3
$6.55M Sell
7,394
-1,093
-13% -$983K 1.66% 12
2024
Q2
$7.68M Sell
8,487
-65
-0.8% -$52K 1.81% 10
2024
Q1
$6.65M Sell
8,552
-1,437
-14% -$1.02M 1.53% 12
2023
Q4
$5.82M Sell
9,989
-289
-3% -$169K 1.44% 14
2023
Q3
$5.52M Buy
10,278
+46
+0.4% +$23.7K 1.49% 14
2023
Q2
$4.8M Sell
10,232
-14
-0.1% -$5.87K 1.27% 17
2023
Q1
$3.52M Buy
10,246
+913
+10% +$308K 1.02% 26
2022
Q4
$3.41M Buy
9,333
+57
+0.6% +$20.2K 1.05% 29
2022
Q3
$3M Sell
9,276
-187
-2% -$59.2K 1.02% 30
2022
Q2
$3.07M Buy
9,463
+5,996
+173% +$1.8M 1.02% 26
2022
Q1
$992K Sell
3,467
-103
-3% -$26.5K 0.28% 84
2021
Q4
$986K Buy
3,570
+106
+3% +$26.9K 0.25% 89
2021
Q3
$800K Buy
3,464
+27
+0.8% +$6.66K 0.22% 97
2021
Q2
$788K Buy
3,437
+94
+3% +$18.9K 0.22% 95
2021
Q1
$624K Sell
3,343
-657
-16% -$129K 0.19% 108
2020
Q4
$675K Sell
4,000
-335
-8% -$50K 0.22% 84
2020
Q3
$641K Buy
4,335
+41
+1% +$6.34K 0.24% 75
2020
Q2
$704K Hold
4,294
0.29% 66
2020
Q1
$595K Hold
4,294
0.31% 65
2019
Q4
$564K Buy
+4,294
New +$498K 0.21% 76

Other funds holding LLY

Great Diamond Partners's LLY Position: Q2 2026 in Review

Great Diamond Partners reduced its Eli Lilly (LLY) stake by 0.42% in Q2 2026, selling an estimated $16.3K and leaving 3,752 shares worth $4.5M. The position accounts for 0.77% of the portfolio, ranked #34.

Great Diamond Partners first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.68M in Q2 2024. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Great Diamond Partners held 3,752 shares of Eli Lilly worth $4.5M as of Q2 2026.
  • Great Diamond Partners sold 16 Eli Lilly shares in Q2 2026, an estimated $16.3K.
  • Eli Lilly made up 0.77% of Great Diamond Partners's portfolio in Q2 2026, its #34 holding.
  • Great Diamond Partners first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • Great Diamond Partners's Eli Lilly position peaked at $7.68M in Q2 2024.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Great Diamond Partners's 13F filing for Q2 2026, filed 17 Jul 2026.